Medicare Changes 2026: Drug Negotiation, MA Oversight, Telehealth & Surprise Billing—What Beneficiaries Should Do

Medicare and insurance landscapes are evolving quickly, and several important shifts affect costs, coverage and how care is delivered. Understanding these changes helps beneficiaries and policyholders make smarter choices during enrollment and when seeking care.

Key trends reshaping Medicare and insurance

– Drug price negotiation and Part D changes: A federal program now allows Medicare to negotiate prices for select high-cost prescription drugs. That can lower out-of-pocket costs for many beneficiaries and influence which drugs appear on plan formularies.

Expect plan sponsors to adjust formularies and tiering to reflect negotiated prices.

– Greater oversight of Medicare Advantage (MA) plans: Regulators are increasing scrutiny of MA plans’ prior authorization practices, network adequacy and billing. New requirements aim to boost transparency about what services require prior authorization and how quickly those decisions are made.

This should reduce surprise denials but means beneficiaries need to check MA plan rules closely before receiving care.

– Protections against surprise billing: Protections limiting balance billing for out-of-network emergency care and certain non-emergency services continue to protect patients. Insurers and providers are refining systems to comply, which may change where providers choose to contract and how networks are structured.

Insurance and Medicare Changes image

– Expanded telehealth and virtual care options: Telehealth access has broadened under Medicare and many private plans, including audio-only options for behavioral health in some cases. This increases convenient access for beneficiaries with mobility or transportation barriers and can lower costs for routine follow-ups.

– Caps on insulin and specialty drug affordability: Cost-sharing caps for insulin under Medicare help many beneficiaries manage diabetes more affordably. At the same time, changes in specialty drug coverage and copay structures under Medicare Part D and commercial plans can shift where patients experience costs.

What beneficiaries should do now

– Review plan notices carefully: Open Annual Notice of Change (ANOC), Evidence of Coverage (EOC), and plan formularies. Look for changes to drug tiers, prior authorization lists, and network providers.

– Re-evaluate Medicare Advantage vs. Original Medicare + Medigap: Increased MA plan oversight may improve protections, but network limits and prior authorization rules still affect access. If predictable care and choice of providers matter most, compare Medigap plus Original Medicare options as well.

– Check prescription coverage proactively: If you take specialty or high-cost medications, verify whether negotiated prices apply and whether your plan’s formulary covers your medicines at an acceptable tier. Consider appeals or exceptions if a needed drug is moved to a nonpreferred tier.

– Use telehealth where appropriate: Virtual visits can be a practical way to manage chronic conditions and routine follow-ups. Confirm coverage rules and whether audio-only visits are accepted for your services.

– Seek help from unbiased counselors: State Health Insurance Assistance Programs (SHIP) and Medicare.gov can help explain plan changes, appeals processes, and enrollment options without cost.

What changes mean for the market

Insurance carriers and plan sponsors are adapting to new regulatory priorities and consumer expectations. Increased transparency and negotiated drug prices may pressure premiums and formulary designs, prompting shifts in plan offerings. For consumers, that translates into both opportunities for lower drug costs and the need to be more proactive about plan review and provider selection.

Staying informed and reviewing coverage annually remain the best defenses against unexpected bills and coverage gaps. Confirm benefits before care, compare options during enrollment, and use counselor resources to navigate changes effectively.